Skip to content
fond-top-image-git copy

Gastrointestinal Pathogen Testing with Acutis Reveal™

Acutis Reveal™ gastrointestinal infection test (GIT) offers a new definition of certainty.

GIT-losange copyReveal™ GIT is an FDA-approved test that can detect up to 14 major gastrointestinal pathogens.

can identify pathogens faster and with greater accuracy than any traditional methods or procedures.

This one-step, non-invasive stool test screens for infectious bacteria, viruses, and parasites in as few as 5 to 24 hours from the time the sample reaches our lab.


Benefits of Acutis Reveal™ GIT at a glance

Simultaneous detection and identification of >90% of the bacteria, viral and parasitic pathogens responsible for infectious diarrhea
Breakthrough technology confirms a 99% Negative Predictive Value, encouraging best-practice treatment, and patient care
Delivery of 95% of results the same day we receive the sample
Prevention of misdiagnoses and subsequent inappropriate use of antibiotics and other potentially costly actions
Minimal sample required for testing

Start testing with us today

tiret copy  

The FDA-approved test can detect up to 14 major gastrointestinal pathogens:

viral targets
  • Adenovirus 40/41

  • Norovirus GI/GII

  • Rotavirus A

bacterial targets
  • Campylobacter

  • Clostridium difficile toxins A & B

  • Enterotoxigenic E. coli (ETEC) LT/ST

  • Escherichia coli O157

  • Salmonella

  • Shiga-like Toxin producing

  • E. coli (STEC) stx1/stx2

  • Shigella Vibrio cholera

Parasitic targets
  • Campylobacter

  • Cryptosporidium

  • Entamoebe histolytica

  • Giardia lamblia

Molecular detection of infectious diseases eases and expedites the process

background-GIT copy-1

Clinical Insights

Reveal™ GIT determines whether or not cases of diarrhea are infectious  

Acutis Reveal™ gastrointestinal pathogen test can identify pathogens faster and with greater accuracy than any traditional methods or procedures.

Highly accurate, the test detects and identifies >90% of infectious agents, providing the certainty clinicians require to provide the most efficient and efficacious patient care, in the shortest amount of time. Gastroenteritis is a growing problem. It too often frustrates the attending physician, always punishes the patient and frequently puts others at risk.  

Acutis Reveal™ offers a novel, proven, state-of-the-art technique that diagnoses gastroenteritis while identifying specific viral, bacterial, or parasitic pathogens.

More about this Service
Reveal™ GIT determines the therapeutic course of action

The test quickly determines the specific bacteria, viral and parasitic pathogens causing the illness. With this knowledge, a medical provider can then take a more specific course of action.

For example, if the bacterial toxin is identified as E. coli (STEC) or Shiga-like Toxin, the use of antibiotics may be appropriate. However, if it proves to be a case of Clostridium difficile toxins A and B, swift action may be called for due to its contagious nature.  

For certain other patients, such as those with IBD, the ability to rule out infections is especially useful. In recent times, these particular pathogens have become notorious as they become better known to the general public.  

Our test goes some way to ascertain a diagnosis while calming the patients’ anxiety.

More about this Service

If you have any questions about Acutis Reveal™ GIT testing

Our molecular disease relations experts are available to speak with you to provide the information you need, to make individual test selections, based on your diagnoses and medical necessity.

Discover all our Acutis Reveal™ tests for infectious diseases